Abstract
Objective
To evaluate the dose response of inhaled nitric oxide (NO) on gas exchange and central haemodynamics in patients with early acute lung injury (ALI).
Design
Prospective, multicentre clinical study.
Setting
General ICUs in university and regional hospitals.
Patients
18 patients with early ALI according to specified criteria.
Interventions
During controlled ventilation an inhalation system was used to deliver NO (1000 ppm in N2) and O2/air to the low pressure fresh gas inlet of a Siemens 900C ventilator. Haemodynamics and pulmonary gas exchange variables were measured at baseline and at stepwise increased inspiratory NO concentrations of 0.1, 0.3, 1, 3, 10, 30 and 100 ppm, each dose being maintained for 15 min. Dose testing was repeated the next day, and the response to prolonged (2 h) NO inhalation at 1 and 10 ppm was also tested.
Measurements and results
Inhalation of NO produced a significant increase in PaO2 (P<0.0025). The degree of response, as well as the optimal NO dose varied in individual patients and between different days. Venous admixture (QVA/QT) was reduced (P<0.02) from 38% (31–46%) to 33% (26–41%). In our patients with early acute lung injury and only a moderate elevation in pulmonary arterial pressure NO inhalation did not reduce mean pulmonary artery pressure significantly, being 27.0 (21–30) mmHg at baseline and 26.0 (21–30) mm Hg at 100 ppm.
Conclusions
This study shows that improvements in arterial oxygenation in response to inhaled NO may show great inter- as well as intraindividual variability, and that improvements in arterial oxygenation occur without any measurable lowering of the pulmonary artery pressure.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet II:319–323
Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142
Moncada S, Higgs A (1993) The L-arginine — nitric oxide pathway. N Engl J Med 329:2002–2012
Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038–2047
Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405
Gerlach H, Rossaint R, Pappert D, Falke KJ (1993) Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23:499–502
Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ (1993) Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19:443–449
Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM (1994) Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80:761–770
Puybasset L, Rouby JJ, Mourgeon E, Stewart TE, Cluzel P, Arthaud M, Poète P, Bodin L, Korinek AM, Viars P (1994) Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 20:319–327
Murray JF, Matthay M, Luce J, Flick M (1988) An expanded definition of the adult respiratory distress syndrome. Am Rev Resp Dis 138:720–723
Knaus WA, Draper EA, Wagner DI, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ (1987) High dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565–1570
Stenqvist O, Kjelltoft B, Lundin S (1993) Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesth Scand 37:687–691
Nathorst Westfelt U, Lundin S, Stenqvist O (1995) Safety aspects on delivery and monitoring of nitric oxide during mechanical ventilation. Acta Anaesthesiol Scand 40:302–310
Nunn JF (1993) Nunn's applied respiratory physiology, 4th edn. Butterworth-Heinemann, London, pp 178–179
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658
Nathorst Westfelt U, Benthin G, Lundin S, Stenqvist O, Wennmalm Å (1995) Conversion of inhaled nitric oxide to nitrate in man. Br J Pharmacol 114:1621–1624
Wysocki M, Delclaux C, Roupie E, Langeron O, Liu N, Herman B, Lemaire F, Brochard L (1994) Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome. Intensive Care Med 20:254–259
Payen DM, Gatecel C, Plaisance P (1993) Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome. Lancet 341:1664
Gaston B, Drazen JM, Loscalzo J, Stamler JS (1994) The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 149:538–551
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lundin, S., Westfelt, U.N., Stenqvist, O. et al. Response to nitric oxide inhalation in early acute lung injury. Intensive Care Med 22, 728–734 (1996). https://doi.org/10.1007/BF01709513
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01709513